KRAS and cancer: TB is associated with LVI, metastasis, MSI, KRAS mutation, 5-y survival. High TB is associated with 2.5 times increased risk for cancer-related death compared to no TB. More than 10 budding cells/ × 200 field is a good cut-off for high TB